Key result
Coronary sinus Reducer linked to ~51% reduction in IMR and improved CFR in CMD patients.
Why the study?
Does Coronary sinus Reducer implantation improve microvascular function and angina symptoms in patients with refractory angina and coronary microvascular dysfunction?
Cohort (n=40)
Does Coronary sinus Reducer implantation improve microvascular function and angina symptoms in patients with refractory angina and coronary microvascular dysfunction?
Coronary sinus Reducer implantation significantly improves coronary microvascular function, angina symptoms, and functional capacity in patients with refractory angina and CMD.
Answers are grounded in this paper and cite their sources.
Reducer implantation was associated with lower IMR in CMD; hypothesis-generating for angina relief pending randomized trials.
BACKGROUND Angina caused by coronary microvascular dysfunction (CMD) represents a particularly challenging clinical scenario. Coronary sinus Reducer implantation is a safe and effective therapy for patients with refractory angina and obstructive coronary artery disease (CAD). We evaluated the efficacy of Reducer implantation in patients with angina and CMD, on microvascular function parameters, angina severity, functional capacity and quality of life (QoL). METHODS Patients with refractory angina, non-obstructive CAD, and evidence of CMD underwent Reducer implantation. Invasive evaluation of microvascular function, including index of microcirculatory resistance (IMR), coronary flow reserve (CFR), resistive reserve ratio (RRR) and microvascular resistance reserve (MRR) was performed at baseline and 4 months after Reducer implantation. Angina symptoms, functional capacity, and QoL were evaluated by Canadian Cardiovascular Society (CCS) class, 6-minute walk test (6mWT), and Seattle Angina Questionnaire (SAQ), respectively, at baseline and 4 months following Reducer implantation. RESULTS Forty patients (median age 68 [IQR 59-77], 55% female) were included. At 4 months, IMR decreased (35 [25-43] to 17 [10-32], p < 0.001), CFR increased (1.6 [IQR 1.3-2.0] to 2.8 [1.9-3.3], p<0.001), RRR increased (1.9 [1.7-2.3] to 2.9 [2.0-3.7], p<0.001) and MRR increased (2.1 [IQR 1.7-2.5] to 3.3 [IQR 2.3-4.0], p<0.001). CCS class improved from a median of III to II, alongside significant improvements in 6mWT distance (300 [IQR 231-400] to 383 [IQR 278-452] meters, p<0.001) and all 5 SAQ domains (p<0.05 for all). CONCLUSIONS Reducer implantation significantly improved coronary microvascular function, angina symptoms, functional capacity, and QoL in patients with angina and evidence of microvascular dysfunction.
No takes yet. Share an insight, caveat, or question.
Konigstein et al. (2026) conducted a cohort in Angina and coronary microvascular dysfunction (n=40). Coronary sinus Reducer implantation was evaluated on Microvascular function parameters including index of microcirculatory resistance (IMR) and coronary flow reserve (CFR) (p=<0.001). Coronary sinus Reducer implantation improved the index of microcirculatory resistance and coronary flow reserve at 4 months in patients with angina and CMD.
Synapse has enriched 10 related papers. Consider them for comparative context: